Effect of low-density lipoprotein apheresis on kinetics of apolipoprotein B in heterozygous familial hypercholesterolemia

被引:13
|
作者
Maugeais, C
Ouguerram, K
Frénais, R
Maugère, P
Charbonnel, B
Magot, T
Krempf, M [1 ]
机构
[1] Hotel Dieu, Clin Endocrinol, F-44093 Nantes 01, France
[2] Hotel Dieu, Ctr Rech Nute Humaine, F-44093 Nantes 01, France
来源
关键词
D O I
10.1210/jc.86.4.1679
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The acute reduction of low-density lipoprotein (LDL) cholesterol obtained by LDL-apheresis allows the role of the high level of circulating LDL on lipoprotein metabolism in heterozygous familial hypercholesterolemia (heterozygous FH) to he addressed. We studied apolipoprotein B (apoB) kinetics in five heterozygous FH patients before and the day after an apheresis treatment using endogenous labeling with [(2)H(3)]leucine. Compared with younger control subjects, heterozygous FH patients before apheresis showed a significant decrease in the fractional catabolic rate of LDL (0.24 +/- 0.08 vs. 0.65 +/- 0.22 day(-1); P < 0.01), and LDL production was increased in heterozygous FH patients (18.9 +/- 7.0 vs. 9.9 +/- 4.2 mg/kg.day; P < 0.05). The modeling of postapheresis apoB kinetics was performed using a nonsteady state condition, taking into account the changing pool size of very low density lipoprotein (VLDL), intermediate density lipoprotein, and LDL apoB. The postapheresis kinetic parameters did not show statistical differences compared with preapheresis parameters in heterozygous FH patients; however, a trend for increases in fractional catabolic rate of LDL (0.24 +/- 0.08 vs. 0.35 +/- 0.09 day(-1); P = 0.067) and the production of VLDL (13.7 +/- 8.3 vs. 21.9 +/- 1.6 mg/ kg day; P = 0.076) was observed. These results suggested that the marked decrease in plasma LDL obtained a short time after LDL-apheresis is able to stimulate LDL receptor activity and VLDL production in heterozygous FH.
引用
收藏
页码:1679 / 1686
页数:8
相关论文
共 50 条
  • [1] Effect of low-density lipoproteins on apolipoprotein AI kinetics in heterozygous familial hypercholesterolemia
    Frénais, R
    Maugeais, C
    Ouguerram, K
    Zaïr, Y
    Bard, JM
    Charbonnel, B
    Magot, T
    Krempf, M
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2001, 50 (06): : 635 - 639
  • [2] Long-term effect of low-density lipoprotein apheresis in patients with heterozygous familial hypercholesterolemia
    Higashikata, T
    Mabuchi, H
    THERAPEUTIC APHERESIS AND DIALYSIS, 2003, 7 (04): : 402 - 407
  • [3] Low-density lipoprotein apheresis in homozygous familial hypercholesterolemia
    Mora, C
    Teruel, JL
    Navarro, JF
    AMERICAN JOURNAL OF CARDIOLOGY, 2001, 88 (02): : 202 - 203
  • [4] Low-density lipoprotein apheresis for the treatment of familial hypercholesterolemia
    Khan, T.
    Chandra, K. M.
    Pham, B.
    VALUE IN HEALTH, 2008, 11 (03) : A208 - A209
  • [5] MARKED OVERPRODUCTION OF LOW-DENSITY LIPOPROTEIN APOLIPOPROTEIN-B IN A SUBJECT WITH HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA - EFFECT OF PORTACAVAL SHUNTING
    GINSBERG, H
    DAVIDSON, N
    LE, NA
    GIBSON, J
    AHRENS, EH
    BROWN, WV
    BIOCHIMICA ET BIOPHYSICA ACTA, 1982, 712 (02) : 250 - 257
  • [6] Atorvastatin in low-density lipoprotein apheresis-treated patients with homozygous and heterozygous familial hypercholesterolemia
    Goldammer, A
    Wiltschnig, S
    Heinz, G
    Jansen, M
    Stulnig, T
    Hörl, WH
    Derfler, K
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2002, 51 (08): : 976 - 980
  • [7] SELECTIVE AND SEMISELECTIVE LOW-DENSITY LIPOPROTEIN APHERESIS IN FAMILIAL HYPERCHOLESTEROLEMIA
    BUSNACH, G
    CAPPELLERI, A
    VACCARINO, V
    FRANCESCHINI, G
    DALCOL, A
    PERRINO, ML
    BRANDO, B
    SIRTORI, C
    MINETTI, L
    BLOOD PURIFICATION, 1988, 6 (03) : 156 - 161
  • [8] Pregnancy in a Woman with Homozygous Familial Hypercholesterolemia Not on Low-Density Lipoprotein Apheresis
    Fahed, Akl C.
    Nassar, Anwar H.
    AJP REPORTS, 2012, 2 (01): : 33 - 35
  • [9] Effect of Low-Density Lipoprotein Apheresis on Circulating Endothelial Progenitor Cells in Familial Hypercholesterolemia
    Ramunni, Alfonso
    Brescia, Paola
    Dambra, Porzia
    Capuzzimati, Laura
    Ria, Roberto
    De Tullio, Giacoma
    Resta, Francesco
    Russi, Gianpaolo
    Vacca, Angelo
    Coratelli, Pasquale
    BLOOD PURIFICATION, 2010, 29 (04) : 383 - 389
  • [10] Effect of Mipomersen, an Apolipoprotein B Synthesis Inhibitor, on Low-Density Lipoprotein Cholesterol in Patients With Familial Hypercholesterolemia
    Akdim, Fatima
    Visser, Maartje E.
    Tribble, Diane L.
    Baker, Brenda F.
    Stroes, Erik S. G.
    Yu, Rosie
    Flaim, Joann D.
    Su, John
    Stein, Evan A.
    Kastelein, John J. P.
    AMERICAN JOURNAL OF CARDIOLOGY, 2010, 105 (10): : 1413 - 1419